Showing 1 - 8 results of 8 for search 'Alexandra Rak', query time: 0.03s Refine Results
  1. 1
    Overview of Nucleocapsid-Targeting Vaccines against COVID-19

    Overview of Nucleocapsid-Targeting Vaccines against COVID-19 by Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines

    Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines by Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests

    Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests by Alexandra Rak, Svetlana Donina, Yana Zabrodskaya, Larisa Rudenko, Irina Isakova-Sivak

    Published 2022-09-01
    Get full text
    Article
  4. 4
    Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model

    Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model by Alexandra Rak, Nikolay Gorbunov, Valeria Kostevich, Alexey Sokolov, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak

    Published 2023-01-01
    Get full text
    Article
  5. 5
    RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples

    RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples by Arina Goshina, Victoria Matyushenko, Daria Mezhenskaya, Alexandra Rak, Anastasia Katelnikova, Denis Gusev, Larisa Rudenko, Irina Isakova-Sivak

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein

    Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein by Polina Prokopenko, Victoria Matyushenko, Alexandra Rak, Ekaterina Stepanova, Anna Chistyakova, Arina Goshina, Igor Kudryavtsev, Larisa Rudenko, Irina Isakova-Sivak

    Published 2023-02-01
    Get full text
    Article
  7. 7
    Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells

    Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells by Alexey Sokolov, Irina Isakova-Sivak, Natalia Grudinina, Daria Mezhenskaya, Elena Litasova, Valeria Kostevich, Ekaterina Stepanova, Alexandra Rak, Ivan Sychev, Olga Kirik, Larisa Rudenko

    Published 2022-02-01
    Get full text
    Article
  8. 8
    Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza

    Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza by Ekaterina Stepanova, Irina Isakova-Sivak, Daria Mezhenskaya, Sergei Niskanen, Victoria Matyushenko, Ekaterina Bazhenova, Alexandra Rak, Pei Fong Wong, Polina Prokopenko, Tatiana Kotomina, Elena Krutikova, Sergei Legotskiy, Bogdan Neterebskii, Tatiana Ostroukhova, Konstantin Sivak, Yana Orshanskaya, Kirill Yakovlev, Larisa Rudenko

    Published 2024-04-01
    Get full text
    Article

Search Tools: